Cargando…
Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report
BACKGROUND: The prognosis for recurrence cases of hormone receptor-positive HER2-negative breast cancer remains poor, and treatment strategies that emphasize quality of life have often been chosen, with few physicians aiming for a cure. Our objective is to assess the validity of such current treatme...
Autores principales: | Yoneto, Toshihiko, Hasumi, Kenichiro, Takahashi, Nobukazu, Seki, Nastuki, Takeda, Yasutaka, Yoshimoto, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169494/ https://www.ncbi.nlm.nih.gov/pubmed/37158934 http://dx.doi.org/10.1186/s13256-023-03902-4 |
Ejemplares similares
-
Case report: two cases of extremely rare primary pure squamous cell carcinoma of the breast
por: Yoneto, Toshihiko, et al.
Publicado: (2018) -
A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies
por: Yoneto, Toshihiko, et al.
Publicado: (2022) -
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
por: Wada, Yoshihiro, et al.
Publicado: (2012) -
Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab
por: Vuyyala, Sowjanya, et al.
Publicado: (2019) -
IL-23p19 and CD5 antigen-like form a possible novel heterodimeric cytokine and contribute to experimental autoimmune encephalomyelitis development
por: Hasegawa, Hideaki, et al.
Publicado: (2021)